{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T06:22:00Z","timestamp":1782886920789,"version":"3.54.5"},"reference-count":35,"publisher":"Sociedade Beneficente Israelita Brasileira Hospital Albert Einstein","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,3,17]]},"DOI":"10.31744\/einstein_journal\/2022ao6412","type":"journal-article","created":{"date-parts":[[2022,3,18]],"date-time":"2022-03-18T12:43:59Z","timestamp":1647607439000},"source":"Crossref","is-referenced-by-count":2,"title":["Association between beta-2 adrenergic receptor variants and clinical outcomes in children and adolescents with acute asthma"],"prefix":"10.31744","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6607-8036","authenticated-orcid":false,"given":"F\u00e1bio Pereira","family":"Much\u00e3o","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0572-449X","authenticated-orcid":false,"given":"Andr\u00e9a Vieira de","family":"Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9855-2249","authenticated-orcid":false,"given":"Juliana Miguita e","family":"Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8431-1997","authenticated-orcid":false,"suffix":"Filho","given":"Luiz Vicente Ribeiro Ferreira da","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"16942","reference":[{"key":"key20220318084331_B1","author":"Global Innicaitive for Asthma","year":"2020","unstructured":"1. Global Innicaitive for Asthma. Global Strategy for Asthma Management and Prevention (2020 update). Fontana (WI): GINA; 2020 [cited 2020 Dez 12]. Available from: https:\/\/ginasthma.org\/wp-content\/uploads\/2020\/06\/GINA-2020-report_20_06_04-1-wms.pdf","journal-title":"Global Strategy for Asthma Management and Prevention (2020 update)"},{"issue":"1","key":"key20220318084331_B2","doi-asserted-by":"crossref","DOI":"10.1590\/1806-3713\/e20190307","article-title":"2020 Brazilian Thoracic Association recommendations for the management of asthma","volume":"46","author":"Pizzichini","year":"2020","unstructured":"2. Pizzichini MM, Carvalho-Pinto RM, Can\u00e7ado JE, Rubin AS, Cerci Neto A, Cardoso AP, et al. 2020 Brazilian Thoracic Association recommendations for the management of asthma. J Bras Pneumol. 2020;46(1):e20190307.","journal-title":"J Bras Pneumol"},{"key":"key20220318084331_B3","author":"Healthcare Improvement Scotland","year":"2019","unstructured":"3. Healthcare Improvement Scotland. Scottish Intercollegiate Guidelines Network (SIGN). SIGN 158. British guideline on the management of asthma. Edinburgh: SIGN; 2019 [cited 2020 Dec 11]. Available from: https:\/\/www.brit-thoracic.org.uk\/document-library\/guidelines\/asthma\/btssign-guideline-for-the-management-of-asthma-2019\/","journal-title":"SIGN 158. British guideline on the management of asthma"},{"issue":"10","key":"key20220318084331_B4","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/S2213-2600(20)30399-4","article-title":"Advances in understanding and reducing the burden of severe asthma in children","volume":"8","author":"Pijnenburg","year":"2020","unstructured":"4. Pijnenburg MW, Fleming L. Advances in understanding and reducing the burden of severe asthma in children. Lancet Respir Med. 2020;8(10):1032-44. Review.","journal-title":"Lancet Respir Med"},{"issue":"11","key":"key20220318084331_B5","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1002\/ppul.23469","article-title":"Albuterol via metered-dose inhaler in children: lower doses are effective, and higher doses are safe","volume":"51","author":"Much\u00e3o","year":"2016","unstructured":"5. Much\u00e3o FP, Souza JM, Torres HC, De Lalibera IB, de Souza AV, Rodrigues JC, et al. Albuterol via metered-dose inhaler in children: lower doses are effective, and higher doses are safe. Pediatr Pulmonol. 2016;51(11):1122-30.","journal-title":"Pediatr Pulmonol"},{"issue":"1","key":"key20220318084331_B6","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S1695-4033(06)70008-X","article-title":"Bronchodilators via metered-dose inhaler with spacer in the pediatric emergency department: what is the dosage?","volume":"64","author":"Benito Fern\u00e1ndez","year":"2006","unstructured":"6. Benito Fern\u00e1ndez J, Trebolazabala Quirante N, Landa Guarriz M, Mintegi Raso S, Gonz\u00e1lez D\u00edaz C. [Bronchodilators via metered-dose inhaler with spacer in the pediatric emergency department: what is the dosage?] An Pediatr (Barc). 2006;64(1):46-51. Spanish.","journal-title":"An Pediatr (Barc)"},{"issue":"3","key":"key20220318084331_B7","doi-asserted-by":"crossref","first-page":"239","DOI":"10.2332\/allergolint.11-RAI-0317","article-title":"Pharmacogenetics of \u03b22-agonists","volume":"60","author":"Hizawa","year":"2011","unstructured":"7. Hizawa N. Pharmacogenetics of \u03b22-agonists. Allergol Int. 2011;60(3):239-46. Review.","journal-title":"Allergol Int"},{"issue":"6","key":"key20220318084331_B8","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1111\/j.1365-2710.2009.01066.x","article-title":"Beta-2 adrenergic receptor genetic polymorphisms and asthma","volume":"34","author":"Hizawa","year":"2009","unstructured":"8. Hizawa N. Beta-2 adrenergic receptor genetic polymorphisms and asthma. J Clin Pharm Ther. 2009;34(6):631-43. Review.","journal-title":"J Clin Pharm Ther"},{"issue":"5 Pt 3","key":"key20220318084331_B9","doi-asserted-by":"crossref","first-page":"S146","DOI":"10.1164\/ajrccm.158.supplement_2.13tac110","article-title":"The beta-adrenoceptor","volume":"158","author":"Johnson","year":"1998","unstructured":"9. Johnson M. The beta-adrenoceptor. Am J Respir Crit Care Med. 1998;158(5 Pt 3):S146-53. Review.","journal-title":"Am J Respir Crit Care Med"},{"key":"key20220318084331_B10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pupt.2017.01.005","article-title":"Beta-2-adrenoreceptor polymorphism at position 16 determines the clinical severity of chronic obstructive pulmonary disease","volume":"43","author":"Emeryk-Maksymiuk","year":"2017","unstructured":"10. Emeryk-Maksymiuk J, Emeryk A, Krawczyk P, Wojas-Krawczyk K, Milanowski J. Beta-2-adrenoreceptor polymorphism at position 16 determines the clinical severity of chronic obstructive pulmonary disease. Pulm Pharmacol Ther. 2017;43:1-5.","journal-title":"Pulm Pharmacol Ther"},{"issue":"12","key":"key20220318084331_B11","doi-asserted-by":"crossref","first-page":"3184","DOI":"10.1172\/JCI119874","article-title":"Association between genetic polymorphisms of the beta2-adrenoceptor and response to albuterol in children with and without a history of wheezing","volume":"100","author":"Martinez","year":"1997","unstructured":"11. Martinez FD, Graves PE, Baldini M, Solomon S, Erickson R. Association between genetic polymorphisms of the beta2-adrenoceptor and response to albuterol in children with and without a history of wheezing. J Clin Invest. 1997;100(12):3184-8.","journal-title":"J Clin Invest"},{"issue":"6","key":"key20220318084331_B12","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1111\/crj.13160","article-title":"An investigation of the association between ADRB2 gene polymorphisms and asthma in Kazakh population","volume":"14","author":"Akparova","year":"2020","unstructured":"12. Akparova A, Aripova A, Abishev M, Kazhiyakhmetova B, Pirmanova A, Bersimbaev R. An investigation of the association between ADRB2 gene polymorphisms and asthma in Kazakh population. Clin Respir J. 2020; 14(6):514-20.","journal-title":"Clin Respir J"},{"issue":"3","key":"key20220318084331_B13","doi-asserted-by":"crossref","first-page":"111","DOI":"10.4103\/0971-6866.73398","article-title":"Pharmacogenomics of pediatric asthma","volume":"16","author":"Gupta","year":"2010","unstructured":"13. Gupta S, Awasthi S. Pharmacogenomics of pediatric asthma. Indian J Hum Genet. 2010;16(3):111-8.","journal-title":"Indian J Hum Genet"},{"issue":"11","key":"key20220318084331_B14","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1172\/JCI4862","article-title":"Polymorphisms of the 5\u2019 leader cistron of the human beta2-adrenergic receptor regulate receptor expression","volume":"102","author":"McGraw","year":"1998","unstructured":"14. McGraw DW, Forbes SL, Kramer LA, Liggett SB. Polymorphisms of the 5\u2019 leader cistron of the human beta2-adrenergic receptor regulate receptor expression. J Clin Invest. 1998;102(11):1927-32.","journal-title":"J Clin Invest"},{"issue":"6","key":"key20220318084331_B15","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1002\/humu.22981","article-title":"HGVS recommendations for the description of sequence variants: 2016 Update","volume":"37","author":"den Dunnen","year":"2016","unstructured":"15. den Dunnen JT, Dalgleish R, Maglott DR, Hart RK, Greenblatt MS, McGowan-Jordan J, et al. HGVS recommendations for the description of sequence variants: 2016 Update. Hum Mutat. 2016;37(6):564-9.","journal-title":"Hum Mutat"},{"issue":"5","key":"key20220318084331_B16","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s00439-006-0169-2","article-title":"Beta 2-adrenergic receptor polymorphisms: pharmacogenetic response to bronchodilator among African American asthmatics","volume":"119","author":"Tsai","year":"2006","unstructured":"16. Tsai HJ, Shaikh N, Kho JY, Battle N, Naqvi M, Navarro D, Matallana H, Lilly CM, Eng CS, Kumar G, Thyne S, Watson HG, Meade K, LeNoir M, Choudhry S, Burchard EG; Study of African Americans, Asthma, Genes Environments (SAGE). Beta 2-adrenergic receptor polymorphisms: pharmacogenetic response to bronchodilator among African American asthmatics. Hum Genet. 2006;119(5):547-57.","journal-title":"Hum Genet"},{"issue":"3","key":"key20220318084331_B17","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1183\/09031936.00023511","article-title":"\u03b22-adrenergic receptor polymorphisms, asthma and COPD: two large population-based studies","volume":"39","author":"Thomsen","year":"2012","unstructured":"17. Thomsen M, Nordestgaard BG, Sethi AA, Tybj\u00e6rg-Hansen A, Dahl M. \u03b22-adrenergic receptor polymorphisms, asthma and COPD: two large population-based studies. Eur Respir J. 2012;39(3):558-66.","journal-title":"Eur Respir J"},{"issue":"3","key":"key20220318084331_B18","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/ppul.21544","article-title":"Beta-adrenergic receptor polymorphisms associated with length of ICU stay in pediatric status asthmaticus","volume":"47","author":"Carroll","year":"2012","unstructured":"18. Carroll CL, Sala KA, Zucker AR, Schramm CM. Beta-adrenergic receptor polymorphisms associated with length of ICU stay in pediatric status asthmaticus. Pediatr Pulmonol. 2012;47(3):233-9.","journal-title":"Pediatr Pulmonol"},{"issue":"9","key":"key20220318084331_B19","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1007\/s100380200074","article-title":"SNP genotyping in the beta(2)-adrenergic receptor by electronic microchip assay, DHPLC, and direct sequencing","volume":"47","author":"Yoshida","year":"2002","unstructured":"19. Yoshida N, Nishimaki Y, Sugiyama M, Abe T, Tatsumi T, Tanoue A, et al. SNP genotyping in the beta(2)-adrenergic receptor by electronic microchip assay, DHPLC, and direct sequencing. J Hum Genet. 2002;47(9):500-3.","journal-title":"J Hum Genet"},{"issue":"4","key":"key20220318084331_B20","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.jpeds.2007.08.034","article-title":"The Pediatric Respiratory Assessment Measure: a valid clinical score for assessing acute asthma severity from toddlers to teenagers","volume":"152","author":"Ducharme","year":"2008","unstructured":"20. Ducharme FM, Chalut D, Plotnick L, Savdie C, Kudirka D, Zhang X, et al. The Pediatric Respiratory Assessment Measure: a valid clinical score for assessing acute asthma severity from toddlers to teenagers. J Pediatr. 2008;152(4):476-80, 480.e1.","journal-title":"J Pediatr"},{"key":"key20220318084331_B21","author":"U.S. National Library of Medicine","unstructured":"21. U.S. National Library of Medicine. National Center for Biotechnology Information (NCBI). dbSNP. Bethesda: NCBI; s.d. [cited 2020 Dec 15]. Available from: https:\/\/www.ncbi.nlm.nih.gov\/snp\/","journal-title":"dbSNP"},{"issue":"6","key":"key20220318084331_B22","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s00408-018-0153-3","article-title":"Beta 2 adrenergic receptor genetic polymorphisms in bronchial asthma: relationship to disease risk, severity, and treatment response","volume":"196","author":"Mohamed-Hussein","year":"2018","unstructured":"22. Mohamed-Hussein AA, Sayed SS, Eldien HM, Assar AM, Yehia FE. Beta 2 adrenergic receptor genetic polymorphisms in bronchial asthma: relationship to disease risk, severity, and treatment response. Lung. 2018;196(6):673-80.","journal-title":"Lung"},{"issue":"3","key":"key20220318084331_B23","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/pr.2017.304","article-title":"B2 adrenergic receptor gene polymorphism effect on childhood asthma severity and response to treatment","volume":"83","author":"Alghobashy","year":"2018","unstructured":"23. Alghobashy AA, Elsharawy SA, Alkholy UM, Abdalmonem N, Abdou MA, Basset MA, et al. B2 adrenergic receptor gene polymorphism effect on childhood asthma severity and response to treatment. Pediatr Res. 2018;83(3):597-605.","journal-title":"Pediatr Res"},{"issue":"10","key":"key20220318084331_B24","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1136\/thoraxjnl-2018-212340","article-title":"\u03b22-Adrenergic genotypes and risk of severe exacerbations in COPD: a prospective cohort study","volume":"74","author":"Ingebrigtsen","year":"2019","unstructured":"24. Ingebrigtsen TS, Vestbo J, Rode L, Marott JL, Lange P, Nordestgaard BG. \u03b22-Adrenergic genotypes and risk of severe exacerbations in COPD: a prospective cohort study. Thorax. 2019;74(10):934-40.","journal-title":"Thorax"},{"issue":"1","key":"key20220318084331_B25","doi-asserted-by":"crossref","DOI":"10.1186\/1710-1492-10-8","article-title":"Asthma: Gln27Glu and Arg16Gly polymorphisms of the beta2-adrenergic receptor gene as risk factors","volume":"10","author":"de Paiva","year":"2014","unstructured":"25. de Paiva AC, Marson FA, Ribeiro JD, Bertuzzo CS. Asthma: Gln27Glu and Arg16Gly polymorphisms of the beta2-adrenergic receptor gene as risk factors. Allergy Asthma Clin Immunol. 2014;10(1):8.","journal-title":"Allergy Asthma Clin Immunol"},{"issue":"6","key":"key20220318084331_B26","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/j.jaip.2016.06.014","article-title":"The Arg\/Arg polymorphism of the ADRB2 is associated with the severity of allergic asthma","volume":"4","author":"Scichilone","year":"2016","unstructured":"26. Scichilone N, Caponetto C, Fagone E, Benfante A, Patern\u00f2 A, Heffler E, et al. The Arg\/Arg polymorphism of the ADRB2 is associated with the severity of allergic asthma. J Allergy Clin Immunol Pract. 2016;4(6):1251-2.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"8","key":"key20220318084331_B27","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1042\/CS20120528","article-title":"Tailored second-line therapy in asthmatic children with the Arg(16) genotype","volume":"124","author":"Lipworth","year":"2013","unstructured":"27. Lipworth BJ, Basu K, Donald HP, Tavendale R, Macgregor DF, Ogston SA, et al. Tailored second-line therapy in asthmatic children with the Arg(16) genotype. Clin Sci (Lond). 2013;124(8):521-8.","journal-title":"Clin Sci (Lond)"},{"issue":"8","key":"key20220318084331_B28","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1042\/CS20120640","article-title":"A tailored approach to asthma management: Arg(16) holds the key?","volume":"124","author":"Sayers","year":"2013","unstructured":"28. Sayers I. A tailored approach to asthma management: Arg(16) holds the key? Clin Sci (Lond). 2013;124(8):517-9.","journal-title":"Clin Sci (Lond)"},{"issue":"1","key":"key20220318084331_B29","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jaci.2015.10.045","article-title":"Childhood asthma exacerbations and the Arg16 \u03b22-receptor polymorphism: a meta-analysis stratified by treatment","volume":"138","author":"Turner","year":"2016","unstructured":"29. Turner S, Francis B, Vijverberg S, Pino-Yanes M, Maitland-van der Zee AH, Basu K, Bignell L, Mukhopadhyay S, Tavendale R, Palmer C, Hawcutt D, Pirmohamed M, Burchard EG, Lipworth B; Pharmacogenomics in Childhood Asthma Consortium. Childhood asthma exacerbations and the Arg16 \u03b22-receptor polymorphism: a meta-analysis stratified by treatment. J Allergy Clin Immunol. 2016;138(1):107-13.e5.","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"key20220318084331_B30","article-title":"Early emergency department treatment of acute asthma with systemic corticosteroids","author":"Rowe","year":"2001","unstructured":"30. Rowe BH, Spooner C, Ducharme FM, Bretzlaff JA, Bota GW. Early emergency department treatment of acute asthma with systemic corticosteroids. Cochrane Database Syst Rev. 2001;(1):CD002178. Review.","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"key20220318084331_B31","article-title":"Intravenous magnesium sulfate for treating children with acute asthma in the emergency department","volume":"4","author":"Griffiths","year":"2016","unstructured":"31. Griffiths B, Kew KM. Intravenous magnesium sulfate for treating children with acute asthma in the emergency department. Cochrane Database Syst Rev. 2016;4(4):CD011050. Review.","journal-title":"Cochrane Database Syst Rev"},{"key":"key20220318084331_B32","article-title":"Interventions for escalation of therapy for acute exacerbations of asthma in children: an overview of Cochrane Reviews","volume":"8","author":"Craig","year":"2020","unstructured":"32. Craig SS, Dalziel SR, Powell CV, Graudins A, Babl FE, Lunny C. Interventions for escalation of therapy for acute exacerbations of asthma in children: an overview of Cochrane Reviews. Cochrane Database Syst Rev. 2020; 8:CD012977.","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"key20220318084331_B33","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S2213-2600(13)70037-7","article-title":"Magnesium sulphate in acute severe asthma in children (MAGNETIC): a randomised, placebo-controlled trial","volume":"1","author":"Powell","year":"2013","unstructured":"33. Powell C, Kolamunnage-Dona R, Lowe J, Boland A, Petrou S, Doull I, Hood K, Williamson P; MAGNETIC study group. Magnesium sulphate in acute severe asthma in children (MAGNETIC): a randomised, placebo-controlled trial. Lancet Respir Med. 2013;1(4):301-8. Erratum in: Lancet Respir Med. 2013;1(4):285.","journal-title":"Lancet Respir Med"},{"issue":"11","key":"key20220318084331_B34","article-title":"Inhaled magnesium sulfate in the treatment of acute asthma","volume":"11","author":"Knightly","year":"2017","unstructured":"34. Knightly R, Milan SJ, Hughes R, Knopp-Sihota JA, Rowe BH, Normansell R, et al. Inhaled magnesium sulfate in the treatment of acute asthma. Cochrane Database Syst Rev. 2017;11(11):CD003898. Review.","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"key20220318084331_B35","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.anai.2013.09.024","article-title":"Heliox-driven \u03b22-agonists nebulization for children and adults with acute asthma: a systematic review with meta-analysis","volume":"112","author":"Rodrigo","year":"2014","unstructured":"35. Rodrigo GJ, Castro-Rodriguez JA. Heliox-driven \u03b22-agonists nebulization for children and adults with acute asthma: a systematic review with meta-analysis. Ann Allergy Asthma Immunol. 2014;112(1):29-34. Review.","journal-title":"Ann Allergy Asthma Immunol"}],"container-title":["Einstein (S\u00e3o Paulo)"],"original-title":[],"language":"en","deposited":{"date-parts":[[2022,3,18]],"date-time":"2022-03-18T12:44:33Z","timestamp":1647607473000},"score":1,"resource":{"primary":{"URL":"https:\/\/journal.einstein.br\/article\/association-between-beta-2-adrenergic-receptor-variants-and-clinical-outcomes-in-children-and-adolescents-with-acute-asthma\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"references-count":35,"alternative-id":["10.31744\/einstein_journal\/2022AO6412"],"URL":"https:\/\/doi.org\/10.31744\/einstein_journal\/2022ao6412","relation":{},"ISSN":["1679-4508","2317-6385"],"issn-type":[{"value":"1679-4508","type":"print"},{"value":"2317-6385","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022]]},"article-number":"eAO6412"}}